Preclinical Evaluation of Liposomal C8 Ceramide as a Potent anti-Hepatocellular Carcinoma Agent
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical Evaluation of Liposomal C8 Ceramide as a Potent anti-Hepatocellular Carcinoma Agent
Authors
Keywords
Apoptosis, MTT assay, Hepatocellular carcinoma, Cell proliferation, Cytotoxicity, Enzyme-linked immunoassays, Hepatocytes, Liposomes
Journal
PLoS One
Volume 11, Issue 1, Pages e0145195
Publisher
Public Library of Science (PLoS)
Online
2016-01-05
DOI
10.1371/journal.pone.0145195
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical development of a C6-ceramide NanoLiposome, a novel sphingolipid therapeutic
- (2015) Mark Kester et al. BIOLOGICAL CHEMISTRY
- C6 ceramide dramatically increases vincristine sensitivity bothin vivoandin vitro, involving AMP-activated protein kinase–p53 signaling
- (2015) Min-Bin Chen et al. CARCINOGENESIS
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MST1 activation by curcumin mediates JNK activation, Foxo3a nuclear translocation and apoptosis in melanoma cells
- (2013) Teng Yu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Activation of AMP-activated protein kinase (AMPK) mediates plumbagin-induced apoptosis and growth inhibition in cultured human colon cancer cells
- (2013) Min-Bin Chen et al. CELLULAR SIGNALLING
- Chemopreventive strategies in hepatocellular carcinoma
- (2013) Siddharth Singh et al. Nature Reviews Gastroenterology & Hepatology
- Hepatocarcinogenesis and Ceramide/Cholesterol Metabolism
- (2012) Albert Morales et al. Anti-Cancer Agents in Medicinal Chemistry
- Ceramide and Apoptosis: Exploring the Enigmatic Connections between Sphingolipid Metabolism and Programmed Cell Death
- (2012) Thomas D. Mullen et al. Anti-Cancer Agents in Medicinal Chemistry
- Perifosine sensitizes UVB-induced apoptosis in skin cells: New implication of skin cancer prevention?
- (2012) Chao Ji et al. CELLULAR SIGNALLING
- mTOR Signaling Pathway and mTOR Inhibitors in Cancer Therapy
- (2012) Alejandro Gomez-Pinillos et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Ursolic acid induces cell death and modulates autophagy through JNK pathway in apoptosis-resistant colorectal cancer cells
- (2012) Cristina P.R. Xavier et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Molecular Targeted Therapies in Hepatocellular Carcinoma
- (2012) Shinji Tanaka et al. SEMINARS IN ONCOLOGY
- Co-administration of perifosine with paclitaxel synergistically induces apoptosis in ovarian cancer cells: More than just AKT inhibition
- (2011) Hui Sun et al. CANCER LETTERS
- Ceramide in Chemotherapy of Tumors
- (2011) Marie-Therese Dimanche-Boitrel et al. Recent Patents on Anti-Cancer Drug Discovery
- Nanoliposomal ceramide prevents in vivo growth of hepatocellular carcinoma
- (2010) H. R. S. Tagaram et al. GUT
- Hepatocellular carcinoma: a global view
- (2010) Ju Dong Yang et al. Nature Reviews Gastroenterology & Hepatology
- Combining Nanoliposomal Ceramide with Sorafenib Synergistically Inhibits Melanoma and Breast Cancer Cell Survival to Decrease Tumor Development
- (2008) M. A. Tran et al. CLINICAL CANCER RESEARCH
- Rapid Distribution of Liposomal Short-Chain Ceramide in Vitro and in Vivo
- (2008) B. S. Zolnik et al. DRUG METABOLISM AND DISPOSITION
- Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
- (2008) Augusto Villanueva et al. GASTROENTEROLOGY
- Differential Dependence of Hypoxia-inducible Factors 1α and 2α on mTORC1 and mTORC2
- (2008) Alfredo Toschi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started